SVA — SINOVAC BIOTECH LTD
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1084201 ·
China
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | 8,138,788,000 | 322,259,000 | 1,673,884,000 |
| Dec 2025 | — | — | — | — | 8,541,725,000 | 488,248,000 | 2,145,473,000 |
| Jun 2025 | — | — | — | — | 11,987,067,000 | 182,626,000 | 5,643,587,000 |
| Dec 2024 | — | — | — | — | 12,337,281,000 | 335,273,000 | 2,043,851,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$2,815,942,000
Inventory
$94,309,000
Receivables
$313,087,000
ST Investments
$5,483,073,000
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
6
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.06T | $1183.46 | — |
| JNJ | JOHNSON & JOHNSON | $653.61B | $271.22 | — |
| ABBV | AbbVie Inc. | $467.12B | $264.34 | — |
| MRK | Merck & Co., Inc. | $367.07B | $148.78 | — |
| NVS | NOVARTIS AG | $276.48B | $145.46 | — |
Recent Insider Activity
No insider activity indexed for this ticker.